The SMC accepted semaglutide for adults with established cardiovascular disease and overweight or obesity, expanding its role beyond weight management.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/semaglutide-accepted-scotland-cv-risk-reduction-2026a1000j6s?src=rss
Author :
Publish date : 2026-06-09 10:52:00
Copyright for syndicated content belongs to the linked Source.